Accera Alternatives & Competitors
12 companies similar to Accera — Pioneering breakthroughs in neurodegenerative therapies for Alzheimer’s, Parkins...
Companies similar to Accera
Satori Pharmaceuticals
Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative di...
Proclara Biosciences
Pioneering therapies to combat neurodegenerative diseases with innovative protein disaggre...
Cantabio Pharmaceuticals, Inc.
Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative d...
Sunnyvale, United States
Serenex
Pioneering innovative treatments in oncology and beyond through a robust Hsp90 inhibitor p...
Rival Readout
Competing with Accera? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ALSP, Inc.
Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative...
La Jolla, United States
Ophidion
Advancing brain-targeted therapies with precision and innovation for neurodegenerative and...
PRAEVENTIX LLC
Pioneering the future of healthcare by developing innovative therapies for bowel, dermatol...
AFFiRiS AG
Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains....
Wien, Austria
Dicerna Pharmaceuticals
Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference te...
Pangolin Therapeutics, Inc.
New therapeutic agents targeting intrinsically disordered proteins.
United States
MAX BioPharma, Inc.
Pioneering new treatments for severe and life-threatening illnesses through innovative sma...
Santa Monica, United Stat...
AmyPore
New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson...
Septemes-les-vallons, Fra...
About Accera
Accera, established in 2001 and based in Broomfield, Colorado, is a pioneering biotechnology firm in the fields of neurodegenerative therapies for Alzheimer’s, Parkinson’s, and age-related memory impairment. The company is focused on the discovery and development of therapeutic drugs aimed at neurodegenerative diseases...
Neurodegenerative Diseases, Therapeutic Drugs, Alzheimer's, Parkinson's, Memory Impairment, Ketasyn, Drug Discovery, Drug Development
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Accera: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Accera on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 28 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
